Image – Interventional flashlight

DOI: 10.4244/EIJ-D-20-00076

Transcatheter aortic valve implantation in unicuspid aortic valve stenosis

Aashish Chopra1, MD; Kalaichelvan Uthayakumaran1, MD; Ravinder Singh Rao2, MD; Mullasari Sankardas Ajit1, MD

Figure 1. Illustration of echocardiogram and CT images. Transthoracic echocardiogram parasternal short-axis (A, Moving image 1) and three-chamber views (B, Moving image 2) showing calcific unicuspid, unicommissural aortic valve with an eccentric opening (arrow). Computed tomography maximum intensity projection (MIP, C) and volume-rendered (VR, D) images showing an unicuspid unicommissural valve and absence of raphae. E) Post TAVI, TTE parasternal long-axis images showing the prosthetic valve in situ. High-resolution CT MIP and VR images showing oval configuration and good expansion of the prosthetic valve (F-H, star, Moving image 3). Post TAVI, TTE five-chamber image showing the prosthetic valve in situ and showing mild paravalvular leak (I, star, Moving image 4). CT image - coronal, sagittal and axial views showing the prosthetic valve in situ (J-L, star).

A 55-year-old male presented with acute left ventricular failure. His transthoracic echocardiogram (TTE) showed a calcific, unicuspid, unicommissural aortic valve with severe stenosis and moderate regurgitation, severe biventricular dysfunction and a dilated ascending aorta (Figure 1, Moving image 1-Moving image 4). After medical stabilisation, he was advised to have surgical aortic valve and aortic root replacement. He was refused surgery in view of severe biventricular dysfunction. He underwent successful transcatheter aortic valve implantation (TAVI) with a 29 mm CoreValve® Evolut™ R (Medtronic, Minneapolis, MN, USA). His post-procedure period was uneventful.

An unicuspid aortic valve is a rare anomaly and the unicommissural variant presents with aortic stenosis in adulthood. Similar to a bicuspid aortic valve, it is associated with severe valve calcification, eccentric opening and aortopathy. Surgical aortic valve replacement along with aortic root replacement remains the appropriate treatment for these patients1. However, TAVI may be considered in patients with high surgical risk and suitable anatomy. The presence of aortopathy, a horizontal aortic root, and an eccentric valve opening makes valve crossing and device delivery challenging. In addition, unicommissural anatomy may result in non-circular expansion of the stent frame at the level of the annulus. Hence, a self-expanding supra-annular valve may offer better haemodynamic performance.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Parasternal short-axis view of the native valve.

Moving image 2. Three-chamber view showing the native valve.

Moving image 3. Post-TAVI CT of the prosthetic valve.

Moving image 4. Five-chamber image of the prosthetic valve.

Volume 15 Number 18
Apr 3, 2020
Volume 15 Number 18
View full issue


Key metrics

Suggested by Cory

State-of-the-Art

10.4244/EIJ-D-24-01069 Nov 14, 2025
Transcatheter treatment of bicuspid aortic valve stenosis
Tchétché D et al
free

10.4244/EIJV7I1A25 May 17, 2011
How should I treat acute valve regurgitation?
Schultz C et al
free

Research Correspondence

10.4244/EIJ-D-25-01160 Jun 1, 2026
First-in-human experience with a heterotopic cross-caval transcatheter tricuspid valve replacement
Estevez-Loureiro R et al

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA10 Sep 18, 2016
Transcatheter aortic valve implantation in bicuspid aortic valve stenosis
Perlman G et al
free
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved